Research & Development: Page 62
-
Transforming R&D
Experts agree that new ways of working are needed if R&D is to continue producing innovative products now and in the future. The past generation of pharmaceutical R&D is over. Life-sciences companies are facing a perfect storm of challenges: eroding margins, decreasing R&D productivit...
By Denise Myshko • Nov. 10, 2010 -
The Corner Office
Strategically Prepared for the Healthcare Market of the Coming Decade David E.I. Pyott, CBE Chairman of the Board and CEO Allergan Inc. With healthcare reform legislation being implemented in the United States as well as increasing efforts by governments all around the world to rein in the rising...
By Taren Grom • Nov. 10, 2010 -
Trendline
Oncology
As investments in cancer R&D stay high, waves of innovative new treatments are on the horizon.
By PharmaVoice staff -
Last Word
The Drug Delivery Market Why do you think the drug delivery sector is growing faster than the pharmaceutical industry? Thornton: This trend is being driven by the challenges the pharma industry faces and the need for improved treatment options for patients as well as improved treatment options f...
By Denise Myshko • Nov. 9, 2010 -
Talent Pool
Biopharmaceutical POOL Michael BAILEY Dr. Donna RADZIK Aveo Pharmaceuticals Bolsters Leadership Aveo Pharmaceuticals, a biopharmaceutical company focused on discovering, developing, and commercializing cancer therapeutics, has appointed Michael Bailey chief commercial officer. Mr. Bailey joins Av...
By PharmaVoice Team • Nov. 9, 2010 -
On the Calendar
November 18-19 2nd Annual VA * DoD * PHS Federal Pricing and Contracts for Bio/Pharmaceutical Companies Courtyard Philadelphia Downtown, Philadelphia PharmaVOICE subscribers receive $400 discount; register using keycode RGR396. Center for Business Intelligence, cbinet.com November 18-19 West Coa...
By PharmaVoice Team • Nov. 9, 2010 -
E-Media
Intouch Solutions’ share»send»save social sharing widget is designed especially for the heavily regulated pharmaceutical industry, offering users control over what content is shared through social networks, sending links via e-mail, and saving or bookmarking information to Web browsers. Recent ev...
By PharmaVoice Team • Nov. 9, 2010 -
What's New
Ireland-based Firecrest has opened a facility in Princeton, N.J., that implements the company’s site performance management systems to help U.S.-based companies solve the challenges faced during clinical trial management and site performance. Firecrest’s products help investigators run complex tr...
By PharmaVoice Team • Nov. 9, 2010 -
PharmaTrax
Sales, Marketing, and R&D Trends from Industry Analysts Featured Briefs: Market Education Should Start Early in Oncology Drug Development Sidebar: Developing Thought Leaders Sales Call Volume Posts Slight Decline in First Half of 2010 Sidebar: Sales Calls for Top Pharma Companies Companies ...
By PharmaVoice Team • Nov. 9, 2010 -
UpFront
Awards Digitas Health Wins OMMA Award Digitas Health was a named a winner in the OMMA Award in the Website Excellence in the Integrated Online Campaign, Health & Pharmaceutical category for the MedImmune Good to Share campaign. The OMMA Awards celebrate the year’s best in online media, market...
By PharmaVoice Team • Nov. 9, 2010 -
Letter from the Editor
The road ahead… Welcome to our annual Year in Preview special issue, which takes a forward-looking approach to identify the trends expected to impact all aspects of the life-sciences industry. We want to thank the almost 100 experts who took the time to raise their voice on the market forces they...
By Taren Grom • Nov. 9, 2010 -
SHOWCASE FEATURE: Managing Data: The Core of Clinical Research
Data are the lifeblood of clinical research. A plethora of new technologies have become available over the last decade to help pharmaceutical companies address some of the challenges related to data management. Companies have made a commitment to EDC and e-clinical platforms, and newer technologi...
By PharmaVoice Team • Sept. 29, 2010 -
Orphan Drugs: Opportunity in Rare Diseases
Rare diseases could be big business for the bio/pharmaceutical industry. A changing landscape in the healthcare and pharmaceutical industries is facilitating efforts to enhance the incentives for pursuing research and development for rare diseases. The development of orphan drugs traditionally wa...
By Denise Myshko • Sept. 28, 2010 -
Talent Pool
Pharmaceutical POOL Timothy HAYES Bayer Adds Global Business Development Oversight Timothy Hayes, currently senior VP and region head for Bayer HealthCare’s Consumer Care division in North America, has assumed the additional responsibility of leading the business unit’s global business developmen...
By PharmaVoice Team • Sept. 28, 2010 -
E-Media
New Electronic and Web-based Applications, Sites, and Technologies Featured Briefs: CenterWatch Service Matches Sponsors, Investigative Sites PPD, Microsoft Collaborate to Improve REMS Management Cegedim Dendrite Streamlines Tracking, Reporting Capabilities QPharma Assists with Marketing Spend ...
By PharmaVoice Team • Sept. 28, 2010 -
What's New
New Healthcare-related Products, Services, and Companies Featured Briefs: Parexel’s Solution Brings Efficiency to Clinical Supply Chain Epitomics Spins Out New Biotech Firm Best Practices Enables Optimization of Key Opinion Leaders Sidebar: Around the Globe Follow Up BEST PRACTICES LLC is a rese...
By PharmaVoice Team • Sept. 28, 2010 -
PharmaTrax
Sales, Marketing, and R&D Trends from Industry Analysts Featured Briefs: Accurate, Rapid Diagnosis Key to Developing Effective Infectious Disease Therapies MSLs Are Increasingly Important for Thought Leader Relationships Pharma Companies Increasing Outsource Manufacturing, Supply Chain IT ...
By PharmaVoice Team • Sept. 28, 2010 -
UpFront
Awards Sanofi-Aventis Receives HBA’s ACE Award The Healthcare Businesswomen’s Association (HBA) has named Sanofi-Aventis US as the winner of the 2010 HBA ACE Award. The Sanofi-Aventis US program, WISE (Women Inspiring Sanofi-Aventis Excellence), is an internal women’s network with more than 1,000...
By PharmaVoice Team • Sept. 28, 2010 -
Letter from the Editor
The appeal of the iPad… It’s hard not to be seduced by the power of the 9.7-inch, high-resolution LED-backlit IPS display and incredible multi-touch capabilities, all bundled in a sleek casing that is light enough to take anywhere. The iPad, what will Steve Jobs and his techno-creatives think of ...
By Taren Grom • Sept. 28, 2010 -
Comparative Effectiveness: Real-World Evidence of Outcomes
Comparative effectiveness research is going to have a huge impact on every stakeholder in healthcare delivery. It requires a much broader view of the healthcare system so that information will exist about a patient’s outcome as he or she moves from diagnosis to treatment in the healthcare system....
By PharmaVoice Team • Aug. 27, 2010 -
SHOWCASE FEATURE: No Longer Lost in Translation
As drug development continues to become more of a global endeavor, it’s more important than ever to ensure that documents, especially informed consent and other patient materials, are correctly translated into local languages to ensure the success of the trial. The increasing number of trials, as...
By PharmaVoice Team • Aug. 26, 2010 -
DIA Recap
DIA editor’s Choice Videos BBK Joan F. Bachenheimer and Matthew Stum Bioclinica Peter Benton Cognizant Nagaraja Srivatsan Cytel Irving Dark i3 Research Dr. Tracy Tsuetaki INC Research Alistair Macdonald Integrated Clinical Solutions Inc. J. Peter Armerding Kendle Ken Hintze, Ph.D. Kendle Drew Kil...
By PharmaVoice Team • Aug. 26, 2010 -
Dr. Leon Smith — Age of Excellence
Imagine an active and comfortable retirement, pursuing your hobbies at will and taking time to enjoy the golden years. Sound like fun? Not to Leon Smith, M.D., it doesn’t. After almost 55 years as a practicing physician, Dr. Smith is every bit as enthralled and impassioned about being a doctor ...
By Kim Ribbink • Aug. 26, 2010 -
Last Word
USING MONOCLONAL ANTIBODIES What are the opportunities for using monoclonal antibodies to treat Alzheimer’s disease? CHAIN: It took a long time to understand the hallmarks of Alzheimer’s disease. The beta amyloid plaques that appear in the brains of patients with Alzheimer’s are just a sign of wh...
By PharmaVoice Team • Aug. 26, 2010 -
PharmaTrax
Sales, Marketing, and R&D Trends from Industry Analysts Featured Briefs: Pharma Could Benefit from Earlier Planning of Counter-Generics Strategies Sidebars: Counter-Generics Strategies Used by All Companies in Past 3 Years (2008-2010) Changes in Medical Treatment in Past Year Due to Economic ...
By PharmaVoice Team • Aug. 26, 2010 -
What's New
Barnett Educational Services has announced the release of updated editions of three of its market intelligence and clinical practices guides. PAREXEL’S BIOPHARMACEUTICAL R&D STATISTICAL SOURCEBOOK 2010/2011 includes statistics, trends, and proprietary market intelligence and analysis on the b...
By PharmaVoice Team • Aug. 26, 2010